Robert Allen Spurr

All filings by Robert Allen Spurr on record concern Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.). The record holds 11 filings, for trades running from 27 May 2020 to 14 April 2022.

On the market, this insider has only sold: 4 sales, €220k in total. Outside the open market, there are 3 option exercises. In 2022 alone, the filings show no purchases and 4 sales.

The record was last updated on 18 April 2022 with an open-market sale (€26k) in Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.). The median gap between a trade and its publication by SEDI is 4 days. Until a filing is published, the market cannot know about the trade. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. This summary is built from SEDI disclosures alone and does not predict where the share price will go.